Wave Life Sciences (WVE) Return on Capital Employed (2016 - 2025)
Historic Return on Capital Employed for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to 0.84%.
- Wave Life Sciences' Return on Capital Employed rose 5000.0% to 0.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.84%, marking a year-over-year increase of 5000.0%. This contributed to the annual value of 0.54% for FY2024, which is 22600.0% up from last year.
- As of Q3 2025, Wave Life Sciences' Return on Capital Employed stood at 0.84%, which was up 5000.0% from 0.78% recorded in Q2 2025.
- Wave Life Sciences' 5-year Return on Capital Employed high stood at 0.45% for Q4 2024, and its period low was 2.09% during Q1 2023.
- In the last 5 years, Wave Life Sciences' Return on Capital Employed had a median value of 0.91% in 2021 and averaged 1.05%.
- As far as peak fluctuations go, Wave Life Sciences' Return on Capital Employed tumbled by -11400bps in 2023, and later surged by 12800bps in 2024.
- Wave Life Sciences' Return on Capital Employed (Quarter) stood at 0.91% in 2021, then plummeted by -93bps to 1.76% in 2022, then rose by 24bps to 1.33% in 2023, then soared by 66bps to 0.45% in 2024, then tumbled by -87bps to 0.84% in 2025.
- Its last three reported values are 0.84% in Q3 2025, 0.78% for Q2 2025, and 0.54% during Q1 2025.